Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study.

McMeekin DS, Lisyanskaya A, Crispens M, Oza AM, Braly P, Doering D, Bayever E, Michiels B, Markman M
Gynecol Oncol. 2009 114 (2): 288-92

PMID: 19476988 · DOI:10.1016/j.ygyno.2009.04.034

MeSH Terms (15)

Adult Aged Aged, 80 and over Antineoplastic Agents, Alkylating Dioxoles Disease-Free Survival Endometrial Neoplasms Female Humans Infusions, Intravenous Middle Aged Neoplasm Recurrence, Local Tetrahydroisoquinolines Trabectedin Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links